← Leaderboards
Robert Warren
University Of California San Francisco
$137,332
Attributed
$137,332
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$137,332 · 1
By mechanism
M01$137,332 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Katherine Kurshan Matthay$7,757,759
- Diane W. Wara$7,985,315
- Zinaida Vexler$18,023,303
- Susan J. Fisher$38,160,909
- Mark A Jacobson$6,824,928
Others in their field
Top investigators on “Adenoviridae”
- David T Curiel · University Of Alabama At Birmingham$7,287,214
- Walter J Koch · Duke University$4,159,497
- Arnold J Berk · University Of California Los Angeles$3,963,905
- Glen R. Nemerow · Scripps Research Institute$3,512,916
- Judith K Gwathmey · Rutgers Biomedical And Health Sciences$3,196,405
- Hildegund C. J. Ertl · Wistar Institute$3,134,983
Research focus
AdenoviridaeArteryClinical ResearchClinical Trial Phase IDrug Administration RoutesDrug Adverse EffectDrug Screening /EvaluationExcretionGene TherapyGenetic ManipulationHuman SubjectHuman Therapy EvaluationImmunotherapyLiver NeoplasmsNeoplasm /Cancer TherapyPharmacokinetics
Grant awards (4)
GENE THERAPY--MALIGNANT TUMORS OF LIVER USING SCH 58500 VIA HEPATIC ARTERY$68,666
M01 · FY2002 · RR
GENE THERAPY--MALIGNANT TUMORS OF LIVER USING SCH 58500 VIA HEPATIC ARTERY$68,666
M01 · FY2001 · RR
GENE THERAPY--MALIGNANT TUMORS OF LIVER USING SCH 58500 VIA HEPATIC ARTERY$0
M01 · FY2001 · RR
GENE THERAPY--MALIGNANT TUMORS OF LIVER USING SCH 58500 VIA HEPATIC ARTERY$0
M01 · FY2000 · RR